Your browser doesn't support javascript.
loading
TCF-1: a maverick in T cell development and function.
Gounari, Fotini; Khazaie, Khashayarsha.
Afiliación
  • Gounari F; Knapp Research Center, Section of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL, USA. Gounari.Fotini@mayo.edu.
  • Khazaie K; Department of Immunology, Mayo Clinic, Scottsdale, AZ, USA. Gounari.Fotini@mayo.edu.
Nat Immunol ; 23(5): 671-678, 2022 05.
Article en En | MEDLINE | ID: mdl-35487986
ABSTRACT
The T cell-specific DNA-binding protein TCF-1 is a central regulator of T cell development and function along multiple stages and lineages. Because it interacts with ß-catenin, TCF-1 has been classically viewed as a downstream effector of canonical Wnt signaling, although there is strong evidence for ß-catenin-independent TCF-1 functions. TCF-1 co-binds accessible regulatory regions containing or lacking its conserved motif and cooperates with other nuclear factors to establish context-dependent epigenetic and transcription programs that are essential for T cell development and for regulating immune responses to infection, autoimmunity and cancer. Although it has mostly been associated with positive regulation of chromatin accessibility and gene expression, TCF-1 has the potential to reduce chromatin accessibility and thereby suppress gene expression. In addition, the binding of TCF-1 bends the DNA and affects the chromatin conformation genome wide. This Review discusses the current understanding of the multiple roles of TCF-1 in T cell development and function and their mechanistic underpinnings.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Wnt / Beta Catenina Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Wnt / Beta Catenina Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos